The FDA told wearable maker Whoop last week that it would not take further enforcement action over the company's blood pressure feature.

In this edition of STAT Health Tech: OpenEvidence adds AI to detect heart disease, and Cadence raises $100 million, and more.

Digital health startup Cadence has raised $100 million at a $1.23 billion valuation to expand its chronic disease management program.

In this edition of STAT Health Tech: A look at what researchers found about if using wearables help people with cardiovascular diseases, and more.

In this edition of AI Prognosis, Brittany Trang takes a close look at ambient scribe developer Abridge's claim about being patient-centered.

In this edition of STAT Health Tech: How a biotech startup turned a failed clinical trial into an AI model, and more.

AI for children requires “randomized controlled trials measuring real developmental outcomes, not engagement metrics,” writes Dua Hassan.

In this edition of STAT Health Tech: HHS watchdog on denials by health insurers, lawmakers target AI denials, and Talkspace's new chatbot offering.

Abridge announced new deals with Eli Lilly and Nvidia as it aims to gain an edge in a competitive market.

Wearables generate a lot of health data, but it exists outside the clinic for the most part. New moves from Oura and Whoop may change that.

In this edition of STAT Health Tech: An update on the Utah pilot that uses a chatbot to renew drug prescriptions, AI scribes for patients, and more.

In this edition of STAT's AI Prognosis: Brittany Trang analyzes the pope's encyclical on artificial intelligence for takeaways relevant for health care.

Growing legislative scrutiny across multiple states targets the corporate structure underlying most direct-to-consumer telehealth businesses.

Two years after General Catalyst said it was buying Ohio safety-net hospital Summa Health, executives shed light on how the “transformation” is going.

Oura Ring 5 arrives with a smaller design, AI-powered health monitoring, blood pressure tracking, breathing insights, and improved fitness features.

In this edition of STAT Health Tech: A new wave of blood pressure monitoring wearables, Stanford asking patients about AI, and more.

In this edition of AI Prognosis, Brittany Trang takes a look at patients' role in how Stanford Health Care adopts AI tools, and more health AI news.

Stanford Health Care started asking patients about new AI tools before they are implemented. Here's what patients are telling them.

In this edition of STAT Health Tech: Early data from a Utah pilot using AI to renew prescriptions, Oura files to go public, and more.

CEO of BigHat Biosciences, which designs antibody therapies using machine-learning, on how AI can, and cannot, help in drug development.

Congressional Democrats are mounting a fresh effort to end a Medicare experiment to use AI to approve or deny care.

23andMe is partnering with HealthEx to allow users to import their medical records, the company said Tuesday at STAT Breakthrough Summit West.

In this edition of STAT Health Tech: Takeaways from a conversation with Dexcom CEO, and updates on WiSeR, and Epic's market share.

Trump's drug discount platform adds 600 generic medications via major online pharmacies.

While confidence in preventing chronic disease remains low among U.S. adults, new data from Abbott suggests wearables are influencing healthier behaviors across generations.

In this edition of STAT Health Tech: Why big digital health players skipped Medicare's ACCESS pilot, Isomorphic's big raise, and more.

In this edition of STAT Health Tech: Hims earnings, Omada's PBM strategy, and the uphill battle faced by new sepsis algorithms.

Roche has signed a deal to acquire PathAI to speed up its use of artificial intelligence to help pathologists diagnose diseases.

In this edition of STAT Health Tech: A health policy blueprint from OpenAI, CGM updates from Dexcom, and push back against whole body scans.

Color Health, which coordinates cancer screening, is moving into a gap it observed — obtaining and coordinating actual cancer care.